The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

Here’s why Restaurant Brands (TSX:QSR) remains a magnificent Canadian stock worth buying right now.

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

Key Takeaways Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.The drug, known as EFX, helped reverse ...